Glycosphingolipid synthesis and proliferation in a renal cell line grown in high glucose

American Journal of Physiology

Volumn 270, Issue 3 PART 2, 1996, Pages

  El Khatib, Mahmoud ^a   Rabin, Norman S ^a   Shayman, James A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Ceramide; Diabetes mellitus; Proximal tubule cell line; Sphingolipids

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; GLUCOSE; GLYCOSPHINGOLIPID;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GROWTH STIMULATION; HYPERGLYCEMIA; KIDNEY CELL; LIPOGENESIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; CELL DIVISION; CELL LINE; CULTURE MEDIA; GLUCOSE; GLYCOSPHINGOLIPIDS; KIDNEY; MICE;

EID: 0029919560     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.270.3.f476     Document Type: Article

References (37)

1. Ärar, M., M. Baum, J. Biber, H. Murer, and M. Levi. Epidermal growth factor inhibits Na-P, cotransport and mRNA in OK cells. Am. J. Phvsiol. 268 (Renal Fluid Electrolyte Physiol. 37): F309-F314, 1995.
2. Ballou, L. R., C. P. Chao, M. A. Holness, S. C. Barker, and R. Raghow. Interleukin-1-mediated PGE^ production and sphingomyelin metabolism. J. Biol. Chem. 267: 20044-20050, 1992.
3. Betts, J. C., A. B. Agranoff, G. J. Nabel, and J. A. Shayman. Dissociation of endogenous cellular ceramide from NF-HcB activation. J. Biol. Chem. 269: 8455-8458, 1994.
4. Craven, P. A., C. M. Davidson, and F. R. DeRubertis. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39: 667-674, 1990.
5. Deshmukh, D. G., N. S. Radin,. V. H. Gattone, and J. A. Shayman. Glycosphingolipid abnormalities in the polycystic (op/? Icpk) mouse. J. Lipid Res. 35: 1611-1618, 1994.
6. Dobrowsky, R. T., C. Kamibayashi, M. C. Mumby, and Y. A. Hannun. Ceramide activates heterotrimeric protein phosphatase2A. J. Biol. Chem. 268: 15523-15530, 1993.
7. Dobrowsky, R. T., M. H. Werner, A. M. Castellino, M. V. Chao, and Y. A. Hannun. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science Wash. DC 265: 1596-1599, 1994.
8. Dressler, K. A., S. Mathias, and R. N. Kolesnick. Tumor necrosis factor-a activates the sphingomyelin signal transduction pathway in a cell-free system. Science Wash. DC 255: 1715-1718, 1992.
9. Goldkorn, T., K. A. Dressler, J., Muindi, N. S. Radin, J. Mendelsohn, D. Menaldino, D. Liotta, and R. N. Kolesnick. Ceramide stimulated epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. J. Biol. Chem. 266: 16092-16097, 1991.
10. Hakomori, S.-I. Bifunctional role of glycosphingolipids. J. Biol. Chem. 265: 18713-18716, 1990.
11. Hannun, Y. A., L. M. Obeid, and R. A. Wolff. The novel second messenger ceramide: identification, mechanism of action, and cellular activity. Ada. LipidRes. 25:43-64, 1993.
12. Haverty, T. P., C. J. Kelly, W. H. Hines, P. S. Amenta, M. Watanabe, R. A. Harper, N. A. Kefalides, and E. G. Neilson. Characterization of a renal tubular epithelial cell line which secretes autologous target antigen for autoimmune experimental interstitial nephritis. J. Cell. Biol. 107: 1359-1368, 1988.
13. Kim, M.-Y., C. Linardic, L. Obeid, and Y. Hannun. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor and -y-interferon. J. Biol. Chum. 266: 484-489, 1991.
14. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. The stress-activated protein kinase subfamily of c-Jun kinases. Na tureLond. 369: 156-60, 1994.
15. Labarca, C., and K. Paigen. A simple rapid and sensitive DNA assay procedure. Anal Biochem. 102:344-352, 1980.
16. Lee, T. H., M. J. Solomon, M. C. Mumby, and M. W. Kirschner. INH, a negative regulator of MPF, is a form of protein phosphatase 2a. Cell 64: 415-423, 1991.
17. Levi, M., P. Wilson, and J. Cooper. Membrane cholesterol is decreased and fluidity is increased in renal MCT cells adapted to a low phosphate medium (Abstract). J. Am. Soi: Nephrol. 2: 775, 1991.
18. Macher, B. A., and J. C. Klock. Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J. Biol. Chem. 255: 2092-2096, 1980.
19. Maurer, H. R. Potential pitfalls of |''H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet. 14: 111-120, 1981.
20. Nakamura, T., A. Abe, K. Balazovich, D. Wu, S. J. Suchard, L. A. Boxer, and J. A. Shayman. Ceramide regulates oxidant release in adherent human neutrophils. J. Biol. Chem. 269: 18384-18389, 1994.
21. Nyengaard, J. R., and R. Rasch. The impact of experimental diabetes mellitus in rats on glomerular capillary number and size. Diabetologia 36: 189-194, 1993.
22. Obeid, L. M., C. M. Linardic, L. A. Korolak, and Y. A. Hannun. Programmed cell death induced by ceramide. Science Wash. DC 259: 1769-1771, 1993.
23. Okazaka, T., R. M. Bell, and Y. A. Hannun. Sphingomyelin turnover induced by vitamin D:1 in HL-60 cells. J. Biol. Chem. 264, 19076-19080, 1989.
24. Petersen, J., J. Ross, and R. Rabkin. Effect, of insulin therapy on established diabetic nephropathy in rats. Diabetes 37: 13461350, 1988.
25. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. Quantitative measurement of sn-l,2-diacylglycerols present in platelets, hepatocytes, and ras- and sistransformed normal rat kidney cells. J. Biol. Chem. 261: 85978600, 1986.
26. Raines, M. A., R. N. Kolesnick, and D. W. Golde. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268: 14572-14575, 1993.
27. Rani, C. S., A. Abe, Y. Chang, N. Rosenzweig, A. R. Saltiel, N. S. Radin, and J. A. Shayman. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase-correlation with cyclin-dependent kinases. J. Biol. Chem. 270: 2859-2867, 1995.
28. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. TNF activates NF-KB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71: 765-776, 1992.
29. Seyer-Hansen, K. Renal hypertrophy in experimental diabetes mellitus. Kidney Int. 23: 643-646,1983.
30. Shayman, J. A., G. D. Deshmukh, S. Mahdiyoun, T. P. Thomas, F. S. Barcelon, and N. S. Radin. Modulation of renal epithelial cell growth by glucosylceramide: association with protein kinase C, sphingosine, and diacylglyceride. J. Biol. Chem. 266: 22968-22974, 1991.
31. Shayman, J. A., S. Mahdiyoun, G. Deshmukh, F. Barcelon, J. Inokuchi, and N. S. Radin. Glucosphingolipid dependence of hormone-stimulated inositol trisphosphate formation. J. Biol. Chem. 265: 12135-12138, 1990.
32. Shiran, A., B. Brenner, A. Laor, and I. Tatersky. Increased risk of cancer in patients with Gaucher disease. Cancer 72: 219-24, 1993.
33. Sidransky, E., D. M. Sherer, and E. I. Ginns. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glycocerebrosidase gene. Pediatr. Res. 32: 494-498, 1992.
34. Smith, P. K, R. I. Krön, G. T. Hermanson, A. K. Mallia, P. H. Gärtner, M. D. Provenzano, E. K. Fujimoto, N. M. Gocke, B. J. Olson, and D. C. Klenk. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85, 1985.
35. Tilton, R. G., L. D. Baier, J. E. Harlow, S. R. Smith, E. Ostrow, and J. R. Williamson. Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/ NAD + . Kidney Int. 41: 778-788,1992.
36. Zador, I. Z., G. D. Deshmukh, R. Kunkel, K. Johnson, N. S. Radin, and J. A. Shayman. Arole for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus. J. Clin. Invest. 91: 797-803, 1993.
37. Ziyadeh, F. N., E. R. Snipes, M. Watanabe, R. J. Alvarez, S. Goldfarb, and T. P. Haverty. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physlol. 28): F704-F714, 1990.